| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.015 | 0.9 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.013 | 0.9 |